Top S&P 500 dividend stocks (yield-first) what’s working in late 2025

14 min read | September 05, 2025 04:44 PM AEST | By Anmol Khazanchi

Dividend yields inside the S&P 500 are all over the map this year. The index’s overall yield is still barely above 1% (give or take a tenth) — which means if you want meaningful cash income from S&P names, you have to be selective and accept that the best payouts tend  to cluster in a few sectors (telecoms, staples, REITs, parts of energy/materials, and a couple of special cases). That’s where a “yield focus” comes in: prioritize the biggest cash yields now, but do it with a tight filter for sustainability so you’re not just catching falling knives. Investopedia

Below, I’ll walk through:

  • A simple, yield-first screening framework that avoids the classic traps

  • A curated roster of S&P 500 names with ~5%–10%+ current yields, with notes on what makes each payout more (or less) durable

  • How to mix these stocks into an income portfolio (and an ETF shortcut if you prefer a basket)

  • What changed in 2025 (two big stories: UPS’s entry into the 7% club and Dow Inc.’s dividend cut)

Numbers shift daily; the commentary below uses the most recent data and company announcements available as of early September 2025, and I’ve pointed to primary sources wherever possible.

How to do “yield focus” without courting disaster

High yield can mean two very different things:

  • a genuine cash-cow company — REIT/utility/staple/telecom — paying a fat, well-covered dividend

  • a “yield trap” where the payout looks huge only because the stock has fallen hard and a cut is on the table

A quick, repeatable check to separate the two:

  • Know the driver of coverage. For regular companies, use free cash flow and the payout ratio (dividends as % of EPS/FCF). For REITs, ignore GAAP EPS and look at AFFO (adjusted funds from operations).

  • Prefer board-affirmed guidance and fresh press releases over old lists; a lot has changed in 2024–2025. Two examples that caught many screens off-guard this year:

    • Dow Inc. (NYSE:DOW) — the board cut the quarterly dividend to $0.35 in July, roughly halving the payout; any list still showing a 5.85%+ yield on the old dividend is outdated. MarketBeat

    • Walgreens Boots Alliance (NASDAQ:WBA) — after a January 2024 cut, the board suspended the dividend entirely in July 2024. It still sits at zero today, so do not rely on “trailing” yield figures you might see on old pages. Dividendpedia - Dividend Information MarketBeat

With that framing, let’s hit the actual names paying you 5%–10%+ today — and what you need to know about each.

The “7% club” (and above): S&P 500’s very highest yields

United Parcel Service (NYSE:UPS) — ~7.5% yield

Why it’s here: A sharp share price drop around Q2 results pushed UPS into rarefied air: a large-cap, investment-grade industrial yielding north of 7%. The board lifted the dividend to $1.64 quarterly in February; the current annual run-rate is $6.56. Management has publicly and repeatedly emphasized the dividend’s primacy. The caveat: the forward payout ratio brushes 100% on 2025 EPS, so it’s being funded out of a combo of earnings and strong free cash flow. That’s workable if margins stabilize, but it leaves less cushion than you’d like if macro turns. Barron's Morningstar Finance Charts
A blue-chip with an unusually high cash yield. Treat it as a value-and-income idea tied to an eventual margin recovery.

LyondellBasell (NYSE:LYB) — ~9.72% yield

Why it’s here: Chemicals are cyclical, and weakness has lifted LYB’s cash yield into the high single digits. The board reaffirmed a $1.37 quarterly dividend in August (annualized $5.48), and buybacks continue — but remember: in commodity-touched businesses, FCF can swing. The appeal is obvious (double-digit yield territory at times), but you want to see discipline on capex and working capital through the cycle. 
A big, shareholder-friendly payer — high yield and genuine cash returns — but still a cyclical.

Conagra Brands (NYSE:CAG) —  7.46% yield

Why it’s here: Food staples with pricing power and stable volumes can fund generous payouts. Conagra kept its dividend at $0.35 quarterly (annual $1.40) with a payout ratio that screening sites peg near the high-50%s — healthy for staples. Shares slumped this year, pushing the yield into the ~7% range. Watch for progress in margins and leverage; the company’s multi-decade dividend habit argues for staying power. conagrabrands.com Finance Charts
A classic staples income name at an unusually high yield — attractive if you believe inflation pressures continue to cool.

Pfizer (NYSE:PFE) — 6.89% yield

Why it’s here: Post-COVID comedown + pipeline resets = depressed share price, elevated yield. The board declared another $0.43 quarterly (Sep. 2 payment), marking the 347th consecutive quarterly payout and keeping the annual run-rate near $1.72. Bears worry about revenue resets and GLP-1 competition; bulls note a fortress balance sheet and commitment to the dividend. Recent pieces have highlighted that the yield approached ~8% at lows; with a small bounce, it sits closer to ~7%. Pfizer Barron's
High yield from a pharma heavyweight; patience depends on your view of the 2026–2028 pipeline and integration of acquisitions.

Healthpeak Properties (NYSE:DOC) — 6.8% yield (healthcare REIT)

Why it’s here: After Healthpeak merged with Physicians Realty and moved to ticker DOC, the board laid out a $1.22 annualized dividend and then shifted to monthly payouts in mid-2025 (a nice psychological boost for income seekers). Current pricing puts the cash yield around ~6.8%. As with all REITs, watch AFFO coverage (not EPS), tenant quality, and debt maturities. Healthcare REIT cash flows tend to be steadier than office or hotels. 
A defensive, monthly-payer REIT rebuilding credibility post-merger, with a meaty yield and sector tailwinds (aging demographics).

Verizon (NYSE:VZ) — 6.2% yield

Why it’s here: Telecom’s high capex and low growth keep multiples and share prices in check — which keeps the yield high. Verizon’s board declared $0.6775 quarterly again this year; payout ratios are reasonable on cash flow, even when EPS looks tight. The yield remains in the ~6% zip code, with a multi-decade record of paying and raising. Verizon MarketBeat
A “sleep-well” income anchor if you’re okay owning a regulated-ish, slow-grower in exchange for dependable cash.

Altria (NYSE:MO) —  6.12% yield

Why it’s here: MO is one of the S&P’s most reliable cash engines. In August the board raised the dividend again to $1.06 quarterly (annual $4.24), explicitly targeting mid-single-digit growth through 2028. Yield moves with the stock, but sits near ~6.3% after the raise. The secular risk case is familiar; the income math, equally so. investor.altria.com
A cornerstone income name with policy and volume headwinds; the board’s dividend-first posture is crystal clear.

Realty Income (NYSE:O) —  5.57% yield (monthly payer)

Why it’s here: “The Monthly Dividend Company®” kept doing its thing — $0.269 per month (annual ~$3.228). That prices to roughly mid-5% yield territory today. This is a global, net-lease REIT with long contracts and escalators; it’s interest-rate sensitive, but highly diversified and investment grade. 
If you want reliable, monthly cash from an S&P 500 REIT with decades of raises, O remains a core building block.

VICI Properties (NYSE:VICI) —  5.19% yield (gaming REIT)

Why it’s here: The Las Vegas landlord with CPI-linked escalators keeps compounding. The board has been raising the payout annually; recent disclosures show an annual dividend around $1.73 (about 5% yield at current prices), and a fresh increase to $0.45 quarterly was just flagged. Long leases, inflation linkage, and BBB- credit underpin the story. 
A quality REIT with built-in rent bumps; yield a whisker above 5% with a credible growth runway.

Simon Property Group (NYSE:SPG) — 4.78% yield (A-mall REIT)

Why it’s here: Premium malls bounced back; SPG kept hiking its quarterly dividend (now $2.15), putting the cash yield just under 5%. It’s not the single-highest REIT yield in the index, but it’s one of the better-covered ones — and the balance sheet is sturdy. 
A high-quality retail landlord with a meaningful payout, benefiting from the bifurcation between strong A-malls and everything else.

Kinder Morgan (NYSE:KMI) —  4.38% yield (midstream C-corp)

Why it’s here: Energy infrastructure names often screen well on yield with decent coverage. KMI sits a bit above 6% by recent reads and tends to keep hikes modest but consistent. (Note: some popular pipelines are MLPs, not S&P 500 components; KMI is a C-corp S&P 500 member.)
If you want energy exposure without commodity price whiplash, midstream cash flows are appealing — just track leverage and contract rollover.

Sector-by-sector notes (what to own for yield, and what to watch)

Telecoms (Verizon; AT&T)
VZ is the higher yielder and has kept its incremental annual raise cadence, funded by hefty free cash flow. AT&T rallied this year on execution and spectrum strategy; the yield compressed and currently sits well below Verizon’s. If you’re choosing purely on yield today, VZ tends to win. Companies Market Cap Barron's
Key watch-items: Fiber build-outs and 5G monetization, lead-sheath remediation costs (in the background), and the debt runway vs. rates.

Staples (Conagra; Altria; Kraft Heinz)
Conagra (NYSE:CAG) is the outlier in staples with a ~7% sticker; the market is basically underwriting a slow-growth/repair period. Altria (MO) is the category’s dividend king — slower revenue, big cash returns. Kraft Heinz (KHC) floats in the ~4½%–5% region depending on price, a notch below the “yield focus” cut but still meaningful. 
Key watch-items: Pricing vs. volumes, private-label competition as inflation cools, and leverage.

Healthcare (Pfizer; healthcare REITs)
Pfizer (NYSE:PFE) is a high-yield pharma with a long dividend record; the risk/reward turns on pipeline confidence and debt pay-down post-M&A. Healthpeak (DOC) offers a similar cash yield via real estate backed by healthcare tenants; its risk is more about lease mix and rates than drug pipelines. Pfizer StockAnalysis
Key watch-items: For PFE: obesity/oncology pipeline milestones and post-COVID revenue base. For DOC: AFFO coverage and refinancing calendar.

REITs (Realty Income, VICI, Simon, Crown Castle)
REITs re-rated higher this year when bond yields eased; they remain attractive for income if you understand the differences. Net lease (Realty Income, O): long contracts, predictable escalators, monthly cash; most sensitive to interest rates. Experiential/gaming (VICI): CPI-linked escalators and long leases; less rate-sensitive than net lease, but cyclical exposure if consumers weaken. Retail A-malls (SPG): still a beneficiary of tenant flight to quality and redevelopment opportunities; yield <5% but backed by scale and liquidity. Towers (Crown Castle, CCI; American Tower, AMT): many investors treat them like “growth REITs”; Crown Castle cut its dividend ~32% earlier this year and now yields ~4% on the new run-rate. Nice reminder: yield stability matters more than the sticker. 

Cyclicals / Materials (UPS; LyondellBasell; Dow Inc.)
UPS is a special, high-profile case: blue-chip with a very high yield due to a cyclical earnings dip. Sustainability hinges on 2026 margin normalization. LyondellBasell (LYB) is what a shareholder-friendly cyclical looks like: high cash payout plus buybacks — but remember, yields here are pro-cyclical. Dow (NYSE:DOW) shows the other side of that coin: when the cycle turns enough, boards will cut. Barron's MarketBeat

A quick refresher on what changed in 2025

  • UPS (NYSE:UPS) joined the “7%+ club.” A selloff around Q2 pushed UPS’s yield over 7%, placing it alongside Pfizer, Conagra, LyondellBasell, and Healthpeak among the S&P 500’s very highest yielders. Management acknowledged the high payout ratio but reiterated support for the dividend on the Q&A. 

  • Dow Inc. (NYSE:DOW) cut its dividend. In July, Dow cut the quarterly dividend to $0.35 from $0.70, resetting the yield base and reminding everyone not to anchor on trailing yields for cyclicals. 

  • Healthpeak (NYSE:DOC) changed ticker and cadence. Post-merger, Healthpeak trades as DOC and now pays monthly; the board affirmed an annualized $1.22 payout in June.

  • Walgreens (NASDAQ:WBA) dividend remains suspended. Any list showing a high WBA yield is out of date; the payout was suspended in July 2024. 

An ETF shortcut for yield hunters who want S&P 500 exposure

If you prefer a basket approach to avoid single-name risk, the SPDR® Portfolio S&P 500 High Dividend ETF (SPYD) tracks an index of the top 80 yielding S&P 500 companies, equal-weighted. Recent sources peg its current yield around ~4.3%–4.5%, lower than the single names above but diversified across sectors. 

Pros: one-ticket diversification; systematic quarterly rebalances to keep yield high.
Cons: little fundamental screen for safety; it can and does pick up names that later cut (e.g., cyclicals during downturns). If you want a quality tilt with income, consider alternatives like SCHD/HDV (not S&P-only), but for S&P-500-only yield, SPYD is the straightforward tool. 

Risk controls that matter more than the headline yield

  • Don’t over-concentrate in one risk factor. It’s easy to wind up heavily tilted to interest-rate-sensitive REITs just because they screen with attractive yields. Blend rate risk (REITs), regulatory risk (telecoms/tobacco), cyclical risk (UPS/chemicals), and pipeline risk (pharma) so no single macro shock dictates your income stream.

  • Track board signals and payout math every quarter. A press release telling you the new dividend per share and payment date is the single most important input; it supersedes stale listicles. (Think: UPS’s penny-raise to $1.64 early this year; Conagra’s steady $0.35; Realty Income’s monthly $0.269; Altria’s step-up to $1.06.) 

  • Beware of “too high to be true.” If you see a double-digit yield in a mature S&P 500 blue-chip, ask what broke. The Dow cut is a fresh reminder — and Walgreens shows how yield can go from “eye-popping” to zero fast. 

  • Use the right metric for the sector. For REITs, judge coverage on AFFO, not EPS. For telecoms, give more weight to free cash flow and capex cadence. For staples, watch gross margin trends and pricing power. For cyclicals, sanity-check payout against mid-cycle earnings, not peak.

  • Diversify the timing of your cash flows. Monthly payers like Realty Income and Healthpeak smooth the cadence; mixing different ex-dates reduces lumpy income.

UPS (NYSE:UPS) — 7.69%+ yield; dividend reaffirmed, payout ratio tight until margins rebound. Position size accordingly. 
LyondellBasell (NYSE:LYB) — 10.11% yield; board affirmed $1.37 quarterly; buybacks active; cyclical caution. 
Conagra (NYSE:CAG) — 7.46%+ yield; $0.35 quarterly; payout ratio reasonable for staples; watch leverage/margins. 
Pfizer (NYSE:PFE) — 6.94% yield; $0.43 quarterly; long dividend history; pipeline will drive 2026–2028. 
Healthpeak (NYSE:DOC) — 6.8% yield; $1.22 annualized, now monthly; healthcare REIT AFFO coverage is the key. 
Verizon (NYSE:VZ) — 6.2% yield; $0.6775 quarterly; strong FCF support; slow grower by design. 
Altria (NYSE:MO) — 6.12% yield; fresh hike to $1.06 quarterly; board explicitly targets mid-single-digit DPS growth. 
Realty Income (NYSE:O) — 5.57% yield; $0.269 monthly; diversified net-lease; rate-sensitive. 
VICI Properties (NYSE:VICI) — 5.19% yield; quarterly dividend recently increased; CPI-linked rent escalators. 
Simon Property (NYSE:SPG) —  4.78% yield; quarterly $2.15; A-mall quality. 
Kinder Morgan (NYSE:KMI) —  4.38%+ yield; steady midstream cash engine; watch debt/contract mix.

Putting it all together (practical “do this next”)

  • Pick your minimum acceptable portfolio yield.

  • Choose one mix above that matches your risk tolerance; start with small allocations and add on weakness that doesn’t change the thesis.

  • Create a dividend calendar around ex-dates so you’re not surprised by lumpy cash. (Monthly payers help here.)

  • Re-underwrite after each quarterly release: scan the press releases for dividend declarations and coverage math; raise a flag any time payout ratios jump or guidance dips.

  • Use SPYD (or similar) for ballast if you want to keep single-name risk in check while still harvesting an above-index yield from S&P 500 constituents. SSGA

A few closing cautions for yield-first strategies

Yields move with price. A stock rally can “lower” your yield overnight even though your cash per share didn’t change. Don’t chase day-to-day fluctuations.

Watch debt maturities in a still-elevated-rate world, especially for REITs and leveraged staples. Refinancing at higher coupons can crimp AFFO and FCF.

Don’t forget taxes and currency. U.S. dividends are paid in USD, and withholding/treaty rules may apply if you hold from outside the U.S. (ask your tax adviser).

Diversify strategies, not just tickers. Blend stable “bond-proxies” (telecoms/REITs) with cyclicals where you believe the cycle is turning.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.